Skip to content

Effect of Karanja Kshara in Pilonidal Sinus

A CLINICAL STUDY TO EVALUATE THE EFFECT OF POST EXCISION KARANJA PRATISARANEEYA KSHARA IN THE MANAGEMENT OF NADIVRANA W.S.R TO PILONIDAL SINUS - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063999
Enrollment
30
Registered
2024-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L050- Pilonidal cyst and sinus with abscess

Interventions

None listed

Sponsors

Dr Shilpa Haligoudar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are having classical signs of Pilonidal sinus. Patients of Nadivrana will be selected irrespective of gender, religion, occupation, and socioeconomic status. Age groups between 15 years to 60 years will be selected. Diabetic patients who are under glycemic control. Only fresh cases will be included.

Exclusion criteria

Exclusion criteria: 1.Patients with known case of Tuberculosis Malignancy And Spinal disorders like Potts disease Scoliosis Inter Vertebral disc Prolapse 2.Patients suffering with Immunocompromised Status 3.Patient contraindicated for Kshara karma like Durbala Bala Bhiru Garbhini Jwara

Design outcomes

Primary

MeasureTime frame
To access the Effect of Chedana paschat karanja pratisaraneeya Kshara in the classical signs and symptoms of NADIVRANA (Pilonidal sinus)Timepoint: 7th day,14th day,21st day,30th day

Secondary

MeasureTime frame
To study the safety of trial drug, Fast & Healthy wound healing along with subside all the clinical symptoms before excision of Nadivrana w.s.r Pilonidal sinusTimepoint: 7th, 14th, 21st, 30th

Countries

India

Contacts

Public ContactShilpa Haligoudar

Sidramappa DANIGOND medical College

sujata.bw@gmail.com8105401470

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026